Saturna Capital Corp Ac Immune Sa Transaction History

Saturna Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$3.5 - $5.16 $38,850 - $57,276	-11,100 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$6.2 - $8.34 $127,100 - $170,970	-20,500 Reduced 64.87%	11,100 $74,000
Q2 2021 Aug 11, 2021	BUY	$6.04 - $8.37 $33,220 - $46,034	5,500 Added 21.07%	31,600 $251,000
Q1 2021 May 14, 2021	BUY	$5.32 - $8.96 $138,852 - $233,856	26,100 New	26,100 $199,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.